Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.271 | 1.641 | 0.99973 | 1.00000 | |
RegionR2 | 1.851 | 1.641 | 0.59909 | 0.95004 | |
RegionR3 | -3.856 | 1.641 | 0.99958 | 1.00000 | |
RegionR4 | 1.823 | 1.641 | 0.35560 | 0.67806 | |
RegionR5 | -3.412 | 1.641 | 0.99969 | 1.00000 | |
RegionR6 | -3.899 | 1.641 | 0.99947 | 1.00000 | |
RegionR7 | 3.369 | 1.641 | 0.12499 | 0.66576 | |
RegionR8 | 2.854 | 1.641 | 0.50152 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.384 | 1.641 | 0.99984 | 1.00000 | |
RegenerationR2 | 0.791 | 1.641 | 0.80836 | 0.99259 | |
RegenerationR3 | 5.342 | 1.641 | 0.22896 | 0.66385 | |
RegenerationR4 | -1.107 | 1.641 | 0.70861 | 0.95685 | |
RegenerationR5 | 3.478 | 1.641 | 0.27530 | 0.70442 | |
RegenerationR6 | 4.116 | 1.641 | 0.25687 | 0.60698 | |
RegenerationBL | -2.989 | 1.641 | 0.99946 | 1.00000 | |
RegenerationTP | -6.11 | 1.641 | 0.24724 | 0.69434 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
2. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
2.751 | 0.976 | 0.856 | - | - | 0.919 | - | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
3. | MligTC455_38647 | 372 | 7.75 | Mlig455_051319 | Neo: - Age: logFC(26M/2M)=-0.649 Region-enriched R2: 3.083/0.04615 |
2.562 | - | 0.951 | 0.760 | - | 0.851 | - | Mlig455_051319 {REF} {Length: 4004} {RNA1509_2582} {RNA1310_1485.1} {RNA815_391} | |
4. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
2.553 | - | 0.974 | 0.751 | - | 0.828 | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
5. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
2.521 | - | 0.972 | - | - | 0.780 | 0.769 | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
6. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 2.481 | - | 1.000 | 0.754 | 0.727 | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
7. | MligTC455_12359 | 34 | 0.71 | Mlig455_036860, Mlig455_053000 | Neo: - Age: - |
2.476 | - | - | 0.760 | 0.762 | 0.954 | - | Mlig455_036860 {REF} {Length: 2052} {Pfam: Ammonium Transporter Family [PF00909.23, score=351.9]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=177, Expect=1e-48]} {Celegans: WBGene00000136, amt-4, Ammonium transporter, [Score=361, Expect=7e-119]} {RNA1310_63464} {RNA815_52017} Mlig455_053000 {REF} {Length: 2052} {Pfam: Ammonium Transporter Family [PF00909.23, score=351.9]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=177, Expect=1e-48]} {Celegans: WBGene00000136, amt-4, Ammonium transporter, [Score=361, Expect=7e-119]} {RNA1310_63464} {RNA815_52017} |
|
8. | MligTC455_38544 | 90 | 1.88 | Mlig455_058882 | Neo: - Age: - Region-enriched R4: 4.873/0.00890 |
2.47 | - | - | - | 0.954 | 0.765 | 0.751 | Mlig455_058882 {REF} {Length: 1700} {RNA1310_40211} {RNA815_8698} | |
9. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
2.401 | - | 0.978 | 0.705 | - | - | 0.718 | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
10. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 1.91 | - | 0.971 | - | - | 0.939 | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
11. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.894 | 0.981 | - | 0.913 | - | - | - | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
12. | MligTC455_50422 | 125 | 2.6 | Mlig455_014719 | Neo: - Age: - Region-enriched R2: 3.621/0.01085 |
GALNT1 | 1.891 | - | 0.921 | - | - | 0.970 | - | Mlig455_014719 {REF} {Length: 2844} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=108.6]; N-terminal domain of galactosyltransferase [PF02709.16, score=19.9]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=328, Expect=8e-108]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=320, Expect=1e-102]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=328, Expect=7e-106]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=320, Expect=9e-103]} {Dmel: FBgn0050463, CG30463, [Score=349, Expect=3e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=359, Expect=2e-117]} {Smed: dd_Smed_v6_4615_0_1, dd_Smed_v6_4615_0_1, [Score=379, Expect=3e-125]} {RNA1509_29632} {RNA1310_10752} {RNA815_14192.1} |
13. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.88 | 0.981 | - | 0.899 | - | - | - | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
14. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
1.876 | - | 0.997 | 0.879 | - | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
15. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 1.864 | - | 0.985 | 0.879 | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
16. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.855 | - | 0.976 | 0.879 | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
17. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1.853 | - | 0.985 | 0.868 | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
18. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1.848 | - | 0.991 | 0.857 | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
19. | MligTC455_17871 | 73 | 1.51 | Mlig455_059152, Mlig455_059165, Mlig455_065536 | Neo: - Age: - |
1.845 | - | 0.979 | 0.866 | - | - | - | Mlig455_059152 {REF} {Length: 321} {NoTransDecoderORF} Mlig455_059165 {REF} {Length: 3349} {Pfam: PIF1-like helicase [PF05970.16, score=103.7]; Helitron helicase-like domain at N-terminus [PF14214.8, score=34.7]} {Celegans: WBGene00018020, F33H12.6, [Score=246, Expect=7e-67]} {Smed: dd_Smed_v6_22430_0_5, dd_Smed_v6_22430_0_5, [Score=47.0, Expect=6e-07]} {RNA1310_3236.1} {RNA815_8758} Mlig455_065536 {REF} {Length: 321} {NoTransDecoderORF} |
|
20. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
1.844 | - | 0.965 | 0.879 | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
21. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.844 | - | 0.983 | 0.861 | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
22. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 1.841 | - | 0.973 | 0.868 | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
23. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.84 | - | 0.961 | 0.879 | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
24. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
1.832 | - | 0.985 | 0.847 | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
25. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
1.831 | - | 0.983 | 0.848 | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
26. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 1.822 | - | 0.964 | 0.858 | - | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
27. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 1.82 | 0.973 | - | - | - | 0.847 | - | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
28. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
1.813 | - | 0.976 | 0.837 | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
29. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
1.809 | - | 0.985 | 0.824 | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
30. | MligTC455_25620 | 44 | 0.92 | Mlig455_026905 | Neo: - Age: Down-Up-Down |
SDCBP | 1.808 | - | 0.961 | 0.847 | - | - | - | Mlig455_026905 {REF} {Length: 3278} {Pfam: PDZ domain [PF00595.26, score=78.4]; PDZ domain [PF17820.3, score=53.7]; PDZ domain [PF13180.8, score=40.6]} {Human: ENSG00000137575, SDCBP, syndecan binding protein, [Score=53.9, Expect=2e-07]; ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=51.6, Expect=1e-06]} {Mouse: ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=56.2, Expect=7e-08]; ENSMUSG00000028249, Sdcbp, syndecan binding protein, [Score=55.8, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0029835, CG5921, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_11951_0_1, dd_Smed_v6_11951_0_1, [Score=175, Expect=2e-49]} {RNA1509_46792} {RNA1310_11662.1} {RNA815_21959} |
31. | MligTC455_14905 | 10 | 0.21 | Mlig455_051912 | Neo: - Age: - |
1.805 | - | - | - | - | 0.953 | 0.852 | Mlig455_051912 {REF} {Length: 1321} {Pfam: Domain of unknown function (DUF4806) [PF16064.7, score=19.6]} {RNA1310_37755} {RNA815_21422} | |
32. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
1.805 | - | 0.980 | 0.825 | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
33. | MligTC455_47259 | 985 | 20.52 | Mlig455_024978 | Neo: - Age: - Region-enriched R2: 2.522/0.00122 |
1.803 | - | 0.973 | 0.830 | - | - | - | Mlig455_024978 {REF} {Length: 514} {RNA1310_63739.2} {RNA815_33907} | |
34. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 1.801 | - | 0.977 | - | - | 0.824 | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
35. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
1.8 | 0.819 | 0.981 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
36. | MligTC455_36197 | 92 | 1.91 | Mlig455_053513 | Neo: - |
TNS1 | 1.797 | 0.833 | - | 0.964 | - | - | - | Mlig455_053513 {REF} {Length: 3575} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=47.7]; SH2 domain [PF00017.26, score=40.2]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=177, Expect=7e-45]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=176, Expect=8e-45]; ENSMUSG00000020422, Tns3, tensin 3, [Score=169, Expect=9e-43]} {Dmel: FBgn0000244, by, blistery, [Score=166, Expect=2e-42]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=181, Expect=5e-51]} {Smed: dd_Smed_v6_4494_0_2, dd_Smed_v6_4494_0_2, [Score=181, Expect=5e-48]} {RNA1509_28824, RNA1509_50496} {RNA1310_7318, RNA1509_28824, RNA1509_50496} {RNA1509_28824, RNA1509_50496, RNA815_6926} |
37. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.793 | - | 0.950 | 0.843 | - | - | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
38. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 1.793 | - | 0.971 | - | 0.822 | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
39. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.791 | - | 0.979 | 0.812 | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
40. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
1.78 | - | 0.985 | 0.795 | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
41. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
1.779 | - | 0.984 | 0.795 | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
42. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1.777 | - | 0.975 | - | 0.802 | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
43. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
1.774 | - | 0.991 | 0.783 | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
44. | MligTC455_52507 | 60 | 1.26 | Mlig455_016440 | Neo: - Age: - Region-enriched R2: 5.871/0.01204 |
1.774 | - | 0.961 | 0.813 | - | - | - | Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267} | |
45. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
1.77 | - | 0.983 | 0.787 | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
46. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 1.769 | 0.951 | 0.818 | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
47. | MligTC455_41571 | 277 | 5.77 | Mlig455_024103 | Neo: - Age: - Region-enriched R2: 6.275/0.00003 |
SULT1C3 | 1.76 | - | - | 0.810 | - | 0.950 | - | Mlig455_024103 {REF} {Length: 1438} {TRANSSPLICED} {Pfam: Sulfotransferase domain [PF00685.29, score=136.6]; Sulfotransferase family [PF13469.8, score=29.1]} {Human: ENSG00000196228, SULT1C3, sulfotransferase family 1C member 3, [Score=119, Expect=8e-31]; ENSG00000197165, SULT1A2, sulfotransferase family 1A member 2, [Score=118, Expect=1e-30]; ENSG00000138068, SULT6B1, sulfotransferase family 6B member 1, [Score=118, Expect=2e-30]; ENSG00000198203, SULT1C2, sulfotransferase family 1C member 2, [Score=115, Expect=2e-29]} {Mouse: ENSMUSG00000038045, Sult6b1, sulfotransferase family, cytosolic, 6B, member 1, [RH, Score=125, Expect=2e-33]} {Dmel: FBgn0037665, St2, Sulfotransferase 2, [Score=108, Expect=5e-27]} {Celegans: WBGene00013748, ssu-1, Suppressor of Stomatin mutant Uncoordination, [Score=109, Expect=5e-27]} {Smed: dd_Smed_v6_38079_0_1, dd_Smed_v6_38079_0_1, [Score=102, Expect=3e-25]} {RNA1509_50382, RNA1509_59532} {RNA1310_7046.1, RNA1509_50382, RNA1509_59532} {RNA1509_50382, RNA1509_59532, RNA815_2250.1} |
48. | MligTC455_41721 | 1545 | 32.19 | Mlig455_000238 | Neo: - Age: logFC(26M/2M)=1.827 Region-enriched R2: 7.263/0.00002 |
1.756 | - | 0.986 | 0.770 | - | - | - | Mlig455_000238 {REF} {Length: 600} {RNA1509_17403} {RNA1310_82552.1} {RNA815_43140.1} | |
49. | MligTC455_37127 | 35 | 0.73 | Mlig455_044059 | Neo: - Age: - |
1.741 | - | - | 0.953 | - | - | 0.788 | Mlig455_044059 {REF} {Length: 582} {RNA1509_40552} {RNA1310_108926} {RNA815_45877.2} | |
50. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1.727 | 0.742 | 0.985 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
51. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.724 | - | 0.978 | 0.746 | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
52. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
1.724 | - | 0.952 | 0.772 | - | - | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
53. | MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
1.715 | - | 0.962 | - | 0.753 | - | - | Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} | |
54. | MligTC455_46418 | 178 | 3.71 | Mlig455_056428 | Neo: - Age: - |
1.715 | - | - | - | 0.742 | 0.973 | - | Mlig455_056428 {REF} {Length: 3626} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=49.8]} {RNA1509_14623} {RNA1310_25579, RNA1509_14623} {RNA1509_14623, RNA815_35028} | |
55. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.709 | - | 0.981 | 0.728 | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
56. | MligTC455_12397 | 18 | 0.37 | Mlig455_021272 | Neo: - Age: - |
SCNN1G | 1.708 | - | - | 0.985 | 0.723 | - | - | Mlig455_021272 {REF} {Length: 2377} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.3]} {Human: ENSG00000166828, SCNN1G, sodium channel epithelial 1 gamma subunit, [Score=52.0, Expect=3e-06]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=49.7, Expect=1e-05]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=3e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=103, Expect=7e-23]} {RNA1310_124026} |
57. | MligTC455_15712 | 181 | 3.76 | Mlig455_030495 | Neo: - Age: - Region-enriched R8: 3.854/0.00430 |
PAX6 | 1.708 | 0.734 | - | - | - | 0.974 | - | Mlig455_030495 {REF} {Length: 4633} {Pfam: 'Paired box' domain [PF00292.20, score=231.0]; Homeodomain [PF00046.31, score=76.2]; Homeodomain-like domain [PF13384.8, score=21.2]} {Human: ENSG00000007372, PAX6, paired box 6, [RH, Score=259, Expect=5e-80]} {Mouse: ENSMUSG00000027168, Pax6, paired box 6, [RH, Score=258, Expect=2e-78]} {Dmel: FBgn0019650, toy, twin of eyeless, [RH, Score=243, Expect=6e-72]} {Celegans: WBGene00006870, vab-3, MAB-18, [RH, Score=236, Expect=2e-70]} {Smed: dd_Smed_v6_17726_0_1, dd_Smed_v6_17726_0_1, [RH, Score=431, Expect=9e-144]} {RNA1310_37223} {RNA815_52287.1} |
58. | MligTC455_27076 | 22 | 0.46 | Mlig455_012170 | Neo: - Age: - |
1.708 | - | - | 0.984 | - | - | 0.724 | Mlig455_012170 {REF} {Length: 537} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_127391} {RNA815_64038} | |
59. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
1.706 | - | 0.984 | - | - | 0.722 | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
60. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
1.7 | - | 0.963 | 0.737 | - | - | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
61. | MligTC455_19795 | 50 | 1.05 | Mlig455_015163, Mlig455_015285 | Neo: - Age: Up-Down-Down |
1.7 | - | - | - | 0.723 | 0.977 | - | Mlig455_015163 {REF} {Length: 4537} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.2]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=7e-119]} {RNA1509_44797} {RNA1310_13221} {RNA815_45407} Mlig455_015285 {REF} {Length: 4094} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=9e-119]} {RNA1509_57431} {RNA1310_13221} {RNA815_45407} |
|
62. | MligTC455_42286 | 59 | 1.22 | Mlig455_042711 | Neo: - Age: - |
GPR83 | 1.694 | - | 0.957 | - | 0.737 | - | - | Mlig455_042711 {REF} {Length: 1706} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=100.2]} {Human: ENSG00000123901, GPR83, G protein-coupled receptor 83, [Score=67.8, Expect=1e-11]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [Score=68.2, Expect=5e-12]; ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=67.4, Expect=1e-11]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=67.4, Expect=9e-12]} {Dmel: FBgn0004622, TkR99D, Tachykinin-like receptor at 99D, [Score=90.9, Expect=2e-19]} {Celegans: WBGene00021897, ser-6, SERotonin/octopamine receptor family, [Score=64.3, Expect=5e-11]} {Smed: dd_Smed_v6_29182_0_1, dd_Smed_v6_29182_0_1, [Score=67.8, Expect=3e-12]} {RNA1310_19087.1} {RNA815_19700} |
63. | MligTC455_20332 | 34 | 0.71 | Mlig455_038515 | Neo: - Age: - |
1.686 | - | - | 0.950 | - | 0.736 | - | Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1} | |
64. | MligTC455_02494 | 237 | 4.93 | Mlig455_004106 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.703/0.00228 |
1.678 | - | 0.957 | - | - | 0.721 | - | Mlig455_004106 {REF} {Length: 917} {RNA1509_21522, RNA1509_4995} {RNA1310_15694.2, RNA1509_21522} {RNA1509_21522, RNA815_5222} | |
65. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 1.676 | - | 0.953 | - | 0.723 | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
66. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
0.996 | - | 0.996 | - | - | - | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
67. | MligTC455_47411 | 30 | 0.62 | Mlig455_038925, Mlig455_039034 | Neo: - Age: logFC(26M/2M)=-0.685 |
0.996 | - | - | 0.996 | - | - | - | Mlig455_038925 {REF} {Length: 941} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_1542.1} {RNA815_3130} Mlig455_039034 {REF} {Length: 1791} {RNA1509_9488} {RNA1310_1542.1} {RNA815_3130} |
|
68. | MligTC455_21858 | 21 | 0.44 | Mlig455_045916 | Neo: - Age: - |
SSTR4 | 0.986 | - | 0.986 | - | - | - | - | Mlig455_045916 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=75.9]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=73.2, Expect=1e-13]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=82.0, Expect=1e-16]} {Dmel: FBgn0250910, Octbeta3R, Octopamine beta3 receptor, [Score=52.0, Expect=6e-07]} {Celegans: WBGene00020712, ckr-1, CholecystoKinin Receptor homolog, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [RH, Score=134, Expect=5e-36]} {RNA1310_148409} |
69. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
70. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 0.985 | - | 0.985 | - | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
71. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
72. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
73. | MligTC455_16728 | 24 | 0.5 | Mlig455_046897 | Neo: - Age: Down-Up-Up |
0.985 | - | - | - | - | 0.985 | - | Mlig455_046897 {REF} {Length: 2092} {RNA1509_37695} {RNA1310_52562.1} {RNA815_33274} | |
74. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.985 | - | 0.985 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
75. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
76. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.985 | - | 0.985 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
77. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
78. | MligTC455_02495 | 2759 | 57.47 | Mlig455_039292 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.530/0.00442 |
0.984 | - | 0.984 | - | - | - | - | Mlig455_039292 {REF} {Length: 910} {RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1310_15694.2, RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1509_35923, RNA1509_4995, RNA1509_7740, RNA815_5222} | |
79. | MligTC455_47410 | 144 | 3 | Mlig455_066471 | Neo: - Age: - |
0.984 | 0.984 | - | - | - | - | - | Mlig455_066471 {REF} {Length: 690} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_3197} {RNA815_3130} | |
80. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
0.983 | 0.983 | - | - | - | - | - | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
81. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
0.983 | - | 0.983 | - | - | - | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
82. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
0.983 | - | 0.983 | - | - | - | - | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
83. | MligTC455_05494 | 51 | 1.06 | Mlig455_004276, Mlig455_004287, Mlig455_004362 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_004276 {REF} {Length: 1694} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1310_39315} {RNA815_27280} Mlig455_004287 {REF} {Length: 4218} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=48.1]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [RH, Score=151, Expect=1e-41]} {RNA1509_28642} {RNA1310_39315} {RNA815_27280} Mlig455_004362 {REF} {Length: 400} {NoTransDecoderORF} {RNA1310_149581} |
|
84. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.981 | - | 0.981 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
85. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
86. | MligTC455_52925 | 10 | 0.21 | Mlig455_024819 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_024819 {REF} {Length: 433} {NoTransDecoderORF} {RNA1310_119495} | |
87. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
0.98 | 0.980 | - | - | - | - | - | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
88. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
0.98 | 0.980 | - | - | - | - | - | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
89. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
0.977 | 0.977 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
90. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 0.977 | 0.977 | - | - | - | - | - | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
91. | MligTC455_45416 | 37 | 0.77 | Mlig455_048800 | Neo: - Age: - |
0.977 | - | - | - | - | - | 0.977 | Mlig455_048800 {REF} {Length: 2619} {NoTransDecoderORF} {RNA1509_55284} {RNA1310_112938} {RNA815_36946} | |
92. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
93. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
0.976 | - | 0.976 | - | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
94. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 0.976 | - | 0.976 | - | - | - | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
95. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.976 | - | 0.976 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
96. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 0.976 | 0.976 | - | - | - | - | - | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
97. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
0.975 | - | 0.975 | - | - | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
98. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.974 | - | 0.974 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
99. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 0.973 | 0.973 | - | - | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
100. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 0.973 | - | 0.973 | - | - | - | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |